CSGALNACT1 Antikörper (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1) (Cy5)

Details for Product anti-CSGALNACT1 Antibody No. ABIN1704257
Antigen
  • CSGalNAcT-1
  • ChGn
  • beta4GalNAcT
  • CHGN
  • 4732435N03Rik
  • Chgn
  • RGD1307618
  • chondroitin sulfate N-acetylgalactosaminyltransferase 1
  • CSGALNACT1
  • csgalnact1
  • Csgalnact1
  • LOC100517735
Reaktivität
Human, Maus, Ratte (Rattus)
71
46
25
6
4
4
4
3
2
2
2
2
2
2
1
Wirt
Kaninchen
66
5
Klonalität
Polyklonal
Konjugat
Dieser CSGALNACT1 Antikörper ist konjugiert mit Cy5
4
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
Applikation
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
44
28
23
12
9
7
Optionen
Immunogen KLH conjugated synthetic peptide derived from human CSGALNACT1
Isotyp IgG
Reinigung Purified by Protein A.
Plasmids, Primers & others Plasmide, Primers & weitere CSGALNACT1 products on genomics-online (e.g. as negative or positive controls)
Antigen
Andere Bezeichnung Csgalnact1 (CSGALNACT1 Antibody Abstract)
Hintergrund

The chondroitin N-acetylgalactosaminyltransferase family includes Beta-1,4-GalNAc-T, Beta-1,4-GalNAc-T2, Beta-1,4-GalNAc-T3 and Beta-1,4-GalNAc-T4. The Beta-1,4-GalNAc-T protein consists of a short N-terminal residue, a transmembrane region and a long C-terminal residue, which includes a catalytic domain and localizes to the Golgi apparatus. Beta-1,4-GalNAc-T utilizes simple ganglioside GM3 as a substrate for more complex gangliosides GM2, GM1 and GD1a. Beta-1,4-GalNAc-T is expressed in normal brain tissues and in various malignant transformed cells, such as malignant melanoma, neuroblastoma and adult T cell leukemia. Mice lacking the Beta-1,4-GalNAc-T protein develop significant and progressive behavioral neuropathies, including deficits in reflexes, strength, coordination and balance. Beta-1,4-GalNAc-T is a potential molecular marker for detecting melanoma cells and monitoring tumor progression.

Synonyms: 4-N-acetylgalactosaminyltransferase 1, Beta4GalNAcT 1, beta4GalNAcT, Beta4GalNAcT-1, Beta4GalNAcT1, CGAT1_HUMAN, ChGn, Chondroitin beta-1, Chondroitin beta1 4 N acetylgalactosaminyltransferase, Chondroitin beta1 4 N acetylgalactosaminyltransferase 1, Chondroitin sulfate N acetylgalactosaminyltransferase 1, Chondroitin sulfate N-acetylgalactosaminyltransferase 1, CSGalNAcT 1, CsGalNAcT-1, Csgalnact1, FLJ11264, FLJ13760.

Gen-ID 55790
Pathways Glycosaminoglycan Metabolic Process
Applikations-hinweise IF(IHC-P) 1:50-200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung 4 °C
Informationen zur Lagerung Store at 4°C
Haltbarkeit 12 months
Haben Sie etwas anderes gesucht?